Home / Semaglutide / United States
US ATC A10BJ06 · updated 2 Nov 2026
Semaglutide shortage in United States
Is there a Semaglutide shortage in United States?
Yes. As of 2 Nov 2026, 3 Semaglutide products are reported short in United States, the first since 4 Jun 2026. No return date has been given. Main reason: not stated.
Also short in Canada, Belgium. All countries.
Affected products in United States
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | Rybelsus, Tablet, 14 mg (NDC 0169-4314-30) discontinuation | Novo Nordisk, Inc. | 4 Jun 2026 | not given | Not stated |
| US | Rybelsus, Tablet, 3 mg (NDC 0169-4303-30) discontinuation | Novo Nordisk, Inc. | 4 Jun 2026 | not given | Not stated |
| US | Rybelsus, Tablet, 7 mg (NDC 0169-4307-30) discontinuation | Novo Nordisk, Inc. | 4 Jun 2026 | not given | Not stated |
Source
U.S. Food and Drug Administration (FDA), Drug Shortages via openFDA. Official list. Shortages the FDA lists as current, plus products to be discontinued; one row per package (NDC).